Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • ranitidine

    Tag: ranitidine

    You Searched For "ranitidine"
    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Medical Dialogues Bureau13 April 2020 2:31 PM IST
    India: Through a recent release with the exchanges, SMS Pharma has provided update against USFDA statement on RanitidineSMS Pharma is one of the...
    USFDA Requests Removal of All Ranitidine Products (Zantac) from the Market

    USFDA Requests Removal of All Ranitidine Products (Zantac) from the Market

    Medical Dialogues Bureau6 April 2020 9:15 AM IST
    The U.S. Food and Drug Administration has announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine...
    Granules India recalls over 2.3 cr ranitidine tablets from US market

    Granules India recalls over 2.3 cr ranitidine tablets from US market

    Farhat Nasim13 Jan 2020 11:59 AM IST
    New Delhi: Drug firm Granules India is recalling over 2.3 crore ranitidine tablets, used to treat ulcers of the stomach and intestines, from the US...
    Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities

    Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities

    Medical Dialogues Bureau10 Nov 2019 9:45 AM IST
    Aurobindo Pharma is second city-based drug company that has initiated the voluntary recall after the FDA announced an investigation into the reported...
    Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA

    Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA

    Medical Dialogues Bureau4 Nov 2019 4:31 PM IST
    New Delhi: Drug firm, Strides Pharma recently announced that the USFDA issued a statement1 on November 1, 2019, providing an update with the latest...
    Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDA

    Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDA

    Medical Dialogues Bureau2 Nov 2019 9:30 AM IST
    Zantac sold over-the-counter in the United States by French drugmaker Sanofi SA, and some of its generic versions, have been recalled due to possible...
    GSK Pharma reports Q2 profit at Rs 503 crore

    GSK Pharma reports Q2 profit at Rs 503 crore

    Medical Dialogues Bureau1 Nov 2019 9:15 AM IST
    GSK Pharmaceuticals continues to drive improved operational efficiencies reflecting in earnings before interest, tax, depreciation and amortisation...
    Drug Alert: CDSCO declares 28 samples including Soframycin, Ranitidine as sub-standard in quality; Details

    Drug Alert: CDSCO declares 28 samples including Soframycin, Ranitidine as sub-standard in quality; Details

    Farhat Nasim24 Oct 2019 2:22 PM IST
    New Delhi: Apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 28 drugs made by certain...
    Dr Reddys recalls Ranitidine products in US over cancer-causing impurity

    Dr Reddys recalls Ranitidine products in US over cancer-causing impurity

    Medical Dialogues Bureau24 Oct 2019 9:30 AM IST
    This recall follows the USFDA's caution note alerting patients and healthcare professionals that NDMA was found in certain samples of ranitidine, Dr...
    No carcinogen found in alternatives of heart burn drug Zantac, generics: USFDA

    No carcinogen found in alternatives of heart burn drug Zantac, generics: USFDA

    Medical Dialogues Bureau24 Oct 2019 9:20 AM IST
    Early tests of alternatives to over-the-counter ranitidine, such as Pepcid, Tagamet, Nexium, Prevacid and Prilosec show no NDMA, the agency said.New...
    Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure

    Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure

    Medical Dialogues Bureau9 Oct 2019 9:30 AM IST
    GSK is recalling all unexpired stock of Zantac from pharmacies due to possible contamination with an impurity N-nitrosodimethylamine (NDMA), the...
    Strides Pharma suspends sale of Ranitidine tab in US

    Strides Pharma suspends sale of Ranitidine tab in US

    Medical Dialogues Bureau27 Sept 2019 9:56 AM IST
    New Delhi: Strides Pharma Science on Friday suspended the sale of Ranitidine tablets after it received an information request from the US health...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok